Tabo-tabo, Petra A.

HRN: 25-11-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/27/2026
08/02/2026
IV
650mg X 30 Mins
OD
Acute Cystitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: